Synthesis of 2-(2-hydroxyethyl)-1-(2-hydroxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline and pseudosymmetry in its crystal structure.
暂无分享,去创建一个
[1] G. Sheldrick. Crystal structure refinement with SHELXL , 2015, Acta crystallographica. Section C, Structural chemistry.
[2] V. Vinogradova,et al. Synthesis of 1-aryltetrahydroisoquinoline alkaloids and their analogs , 2013, Chemistry of Natural Compounds.
[3] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[4] Robin Taylor,et al. Mercury: visualization and analysis of crystal structures , 2006 .
[5] M. Takeuchi,et al. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists. , 2005, Journal of medicinal chemistry.
[6] Alba Chimirri,et al. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist. , 2003, Journal of medicinal chemistry.
[7] T. Olszak,et al. X-ray structure investigations of potential beta-blockers. II.6,7-Dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline. , 1996, Acta crystallographica. Section C, Crystal structure communications.
[8] J. Donnelly. Saint , 2018, Encyclopedia of Early Modern History Online.
[9] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.